Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00270998 · ClinicalTrials.gov registry record · Phase 3
ATLAS: Ambulatory Treatments for Leakage Associated With Stress
A Phase 3 study, sponsored by NICHD Pelvic Floor Disorders Network.
- Completed
- Registry status
- Phase 3
- Development phase
- 445
- Enrollment target
NCT00270998 is a Phase 3 study that has completed, run by NICHD Pelvic Floor Disorders Network. The registered enrollment target is 445 participants.
The verdict
NCT00270998, a Phase 3 study, has completed, sponsored by NICHD Pelvic Floor Disorders Network.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 445 participants
- Enrollment target
Study Summary
Stress urinary incontinence is the uncontrollable leakage of urine with physical effort or stress, such as coughing, sneezing, or exercise. Treatment for stress incontinence can be surgical or non-surgical. Different non-surgical treatments include pelvic muscle exercises and pessary use. Pelvic muscle exercises (often known as "Kegel" exercises) train and strengthen the pelvic muscles and improve incontinence. A pessary is a medical device that fits inside the vagina to give the urethra and bladder extra support and prevent or reduce urinary incontinence. Exercises and pessary use can help women with stress incontinence but it is not known which treatment is better, or if a combination of the two treatments at the same time is best. This study will determine whether pelvic muscle training and exercises, pessary use, or a combination of both exercises and pessary is most effective at improving incontinence in women. The study's primary hypothesis is that pessary use is more effective than pelvic muscle exercises after 3 months of treatment.
Interventions
- BEHAVIORAL Behavioral Therapy
- DEVICE Intravaginal Pessary
- DEVICE Pessary combined with behavioral therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 445 participants |
| Start Date | 2005-06 |
| Est. Completion | 2008-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00270998
The ClinicalTrials.gov registry entry for NCT00270998 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 445 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NICHD Pelvic Floor Disorders Network, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Behavioral Therapy is the first listed.
NCT00270998 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00270998 about?
NCT00270998 is a clinical study titled "ATLAS: Ambulatory Treatments for Leakage Associated With Stress". Stress urinary incontinence is the uncontrollable leakage of urine with physical effort or stress, such as coughing, sneezing, or exercise. Treatment for stress incontinence can be surgical or non-surgical. Different non-surgical treatments include pelvic muscle exercises and pessary use. Pelvic mus...
What is the current status of trial NCT00270998?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 445 participants. The study started on 2005-06. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00270998?
The interventions under investigation include: Behavioral Therapy (BEHAVIORAL), Intravaginal Pessary (DEVICE), Pessary combined with behavioral therapy (DEVICE).
Who is sponsoring clinical trial NCT00270998?
This trial is sponsored by NICHD Pelvic Floor Disorders Network, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.